start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Histophilus somni in young calves

Inici Coneixement Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Histophilus somni in young calves

Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Histophilus somni in young calves

The aim of this study was to demonstrate the protection conferred in calves by HIPRABOVIS® SOMNI/Lkt through a challenge infection with Histophilus somni, one of the bacterial agent commonly isolated from pneumonic lungs in cattle and associated with clinical BRD (Terry 2013).

Descarregueu aquest article

2,29 MB

Sobre aquest article

Autors

Foix, A., Relancio B., Casademunt, S., March, R.

Resum

HIPRABOVIS® SOMNI/Lkt proved to be effective in front of an experimental infection with H. somni presenting significantly fewer respiratory problems and reducing percentage and severity of pneumonic lesions. Therefore, the clinical and economic consequences associated with the pathogenesis of this bacterial agent could be reduced using this vaccine, as well as the risk of suffering clinical BRD.

Productes relacionats

HIPRABOVIS® SOMNI/Lkt

Publicacions relacionades

Analysis of the antibodies induced by UBAC® vaccination Using HIPRABOVIS® SOMNI/LKT to control BRD in dairy calves: a field trial in Portugal Histophilus somni infection: an outbreak in cattle in Cental Italy

Compartir

start portlet menu bar

Histophilus somni in young calves - Vaccine

Display portlet menu
end portlet menu bar

Veure també

Publicacions

Immune response of dairy cows following vaccination with UBAC® in a clinical trial

13-06-2019
Post

Udder Health by HIPRA and CowSignals: 1 + 1 = 3

12-05-2017
Notícies

HIPRA presents INMEVA, the new inactivated vaccine against abortions caused by Chlamydia a...

12-09-2019